Finanzwire Finanzwire
Basculer en Français
10820 Companies
234646 Keywords
163503 Articles
125574 Press releases
Headlines Articles Press releases BioGX Remove
  1. Home
  2. Companies
  3. BioGX
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 01/11/2024 at 18:00, 2 years 7 months ago

    BioGX Expands PCR Test Menu at State Departments of Health

    BioGX, a leading provider of molecular diagnostic solutions, has announced the expansion of its test menu to support state Departments of Health with the addition of its Candida auris assay. This expansion will provide access to BioGX's molecular assays designed for speed, precision, and reliability, empowering healthcare professionals with the best tools available to improve public health outcomes.
    Healthcare Professionals BioGX Molecular Diagnostic Solutions Candida Auris Assay Public Health
    Logo of BioGX
  • PRESS RELEASE

    published on 07/24/2023 at 06:00, 3 years ago

    BioGX Candida Auris PCR Assay Global Adoption Accelerates

    Logo of BioGX
  • PRESS RELEASE

    published on 03/23/2023 at 19:00, 3 years 4 months ago

    BioGX Candida Auris PCR Assay Adoption Accelerates

    Logo of BioGX
  • PRESS RELEASE

    published on 02/28/2023 at 21:00, 3 years 5 months ago

    BioGX Ships First Batch of pixl(TM) Real-Time PCR Platform to US Laboratories

    Logo of BioGX
Accesswire
  • Published on 08/12/2026 at 00:00, 5 hours 18 minutes ago

    Organto Foods Reports Record Second Quarter 2026 Financial Results

  • Published on 08/11/2026 at 23:40, 5 hours 38 minutes ago

    RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000

  • Published on 08/11/2026 at 23:15, 6 hours 3 minutes ago

    Fermi and Hillcore Energy Capital Announce 2.6 Gigawatt Power Strategic Alliance for Project Matador

  • Published on 08/11/2026 at 23:00, 6 hours 18 minutes ago

    Prospectiva Resources Ltd. Completes Qualifying Transaction

  • Published on 08/11/2026 at 22:55, 6 hours 23 minutes ago

    NV Gold Announces Non-Brokered Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 08/12/2026 at 00:18, 4 hours 59 minutes ago

    EQS-Adhoc: Hawesko Holding SE updates forecast for the 2026 financial year

  • Published on 08/11/2026 at 22:10, 7 hours 7 minutes ago

    Quantinuum Reports Second Quarter 2026 Results

  • Published on 08/11/2026 at 22:05, 7 hours 12 minutes ago

    Quantinuum and Oracle Partner to Accelerate Hybrid Quantum Compute Adoption on Oracle Cloud Infrastructure

  • Published on 08/11/2026 at 18:59, 10 hours 18 minutes ago

    EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: SOEC realignment leads to adjustment of FY 2025/26 EBIT guidance; Order intake and sales outlook updated based on current business performance

  • Published on 08/11/2026 at 17:50, 11 hours 27 minutes ago

    Bilfinger Extends Contract of Group CEO Thomas Schulz by Another Five Years

View all EQS
Les Echos
  • Published on 08/10/2026 at 18:00, 1 day 11 hours ago

    AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026

  • Published on 08/10/2026 at 17:45, 1 day 11 hours ago

    Weekly share buyback

  • Published on 08/10/2026 at 11:53, 1 day 17 hours ago

    GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

  • Published on 08/10/2026 at 11:36, 1 day 17 hours ago

    GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026

  • Published on 08/10/2026 at 09:22, 1 day 19 hours ago

    Number of shares and voting rights - July 2026 (In French only)

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy